# Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis

> **NCT05101447** · PHASE2 · WITHDRAWN · sponsor: **Children's Hospital Medical Center, Cincinnati**

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT05101447
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-07
- **Primary completion:** 2024-01
- **Final completion:** 2024-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding not secured
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05101447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05101447, "Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05101447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*